These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

485 related items for PubMed ID: 25744243

  • 1. Enhanced expression of suppresser of cytokine signaling 3 inhibits the IL-6-induced epithelial-to-mesenchymal transition and cholangiocarcinoma cell metastasis.
    Zhou QX, Jiang XM, Wang ZD, Li CL, Cui YF.
    Med Oncol; 2015 Apr; 32(4):105. PubMed ID: 25744243
    [Abstract] [Full Text] [Related]

  • 2. Hepatocyte nuclear factor 6 inhibits the growth and metastasis of cholangiocarcinoma cells by regulating miR-122.
    Zhu H, Mi Y, Jiang X, Zhou X, Li R, Wei Z, Jiang H, Lu J, Sun X.
    J Cancer Res Clin Oncol; 2016 May; 142(5):969-80. PubMed ID: 26825606
    [Abstract] [Full Text] [Related]

  • 3. Gankyrin promotes tumor growth and metastasis through activation of IL-6/STAT3 signaling in human cholangiocarcinoma.
    Zheng T, Hong X, Wang J, Pei T, Liang Y, Yin D, Song R, Song X, Lu Z, Qi S, Liu J, Sun B, Xie C, Pan S, Li Y, Luo X, Li S, Fang X, Bhatta N, Jiang H, Liu L.
    Hepatology; 2014 Mar; 59(3):935-46. PubMed ID: 24037855
    [Abstract] [Full Text] [Related]

  • 4. Humanised antihuman IL-6R antibody with interferon inhibits renal cell carcinoma cell growth in vitro and in vivo through suppressed SOCS3 expression.
    Oguro T, Ishibashi K, Sugino T, Hashimoto K, Tomita S, Takahashi N, Yanagida T, Haga N, Aikawa K, Suzutani T, Yamaguchi O, Kojima Y.
    Eur J Cancer; 2013 May; 49(7):1715-24. PubMed ID: 23274199
    [Abstract] [Full Text] [Related]

  • 5. E3 ubiquitin ligase FBW7α inhibits cholangiocarcinoma cell proliferation by downregulating c-Myc and cyclin E.
    Li M, Ouyang L, Zheng Z, Xiang D, Ti A, Li L, Dan Y, Yu C, Li W.
    Oncol Rep; 2017 Mar; 37(3):1627-1636. PubMed ID: 28184929
    [Abstract] [Full Text] [Related]

  • 6. Scabraside D Derived from Sea Cucumber Induces Apoptosis and Inhibits Metastasis via iNOS and STAT-3 Expression in Human Cholangiocarcinoma Xenografts.
    Assawasuparerk K, Rawangchue T, Phonarknguen R.
    Asian Pac J Cancer Prev; 2016 Mar; 17(4):2151-7. PubMed ID: 27221911
    [Abstract] [Full Text] [Related]

  • 7. The Prognostic Role of SOCS3 and A20 in Human Cholangiocarcinoma.
    Wang Y, Wan M, Zhou Q, Wang H, Wang Z, Zhong X, Zhang L, Tai S, Cui Y.
    PLoS One; 2015 Mar; 10(10):e0141165. PubMed ID: 26485275
    [Abstract] [Full Text] [Related]

  • 8. High suppressor of cytokine signaling-3 expression impairs STAT3-dependent protective effects of interleukin-22 in ulcerative colitis in remission.
    Xu AT, Li Y, Zhao D, Shen J, Xu XT, Qiao YQ, Zhu MM, Wang TR, Cui Y, Ai LY, Ran ZH.
    Inflamm Bowel Dis; 2015 Feb; 21(2):241-50. PubMed ID: 25545374
    [Abstract] [Full Text] [Related]

  • 9. Inhibitory effects of suppressor of cytokine signaling 3 on inflammatory cytokine expression and migration and proliferation of IL-6/IFN-γ-induced vascular smooth muscle cells.
    Xiang S, Dong NG, Liu JP, Wang Y, Shi JW, Wei ZJ, Hu XJ, Gong L.
    J Huazhong Univ Sci Technolog Med Sci; 2013 Oct; 33(5):615-622. PubMed ID: 24142708
    [Abstract] [Full Text] [Related]

  • 10. FTY720 inhibits proliferation and epithelial-mesenchymal transition in cholangiocarcinoma by inactivating STAT3 signaling.
    Lu Z, Wang J, Zheng T, Liang Y, Yin D, Song R, Pei T, Pan S, Jiang H, Liu L.
    BMC Cancer; 2014 Oct 25; 14():783. PubMed ID: 25344679
    [Abstract] [Full Text] [Related]

  • 11. The H4 histamine receptor agonist, clobenpropit, suppresses human cholangiocarcinoma progression by disruption of epithelial mesenchymal transition and tumor metastasis.
    Meng F, Han Y, Staloch D, Francis T, Stokes A, Francis H.
    Hepatology; 2011 Nov 25; 54(5):1718-28. PubMed ID: 21793031
    [Abstract] [Full Text] [Related]

  • 12. Forced overexpression of FBP1 inhibits proliferation and metastasis in cholangiocarcinoma cells via Wnt/β-catenin pathway.
    Zhao W, Yang S, Chen J, Zhao J, Dong J.
    Life Sci; 2018 Oct 01; 210():224-234. PubMed ID: 30193944
    [Abstract] [Full Text] [Related]

  • 13. Sustained IL-6/STAT-3 signaling in cholangiocarcinoma cells due to SOCS-3 epigenetic silencing.
    Isomoto H, Mott JL, Kobayashi S, Werneburg NW, Bronk SF, Haan S, Gores GJ.
    Gastroenterology; 2007 Jan 01; 132(1):384-96. PubMed ID: 17241887
    [Abstract] [Full Text] [Related]

  • 14. MicroRNA-21 regulates biological behavior by inducing EMT in human cholangiocarcinoma.
    Liu Z, Jin ZY, Liu CH, Xie F, Lin XS, Huang Q.
    Int J Clin Exp Pathol; 2015 Jan 01; 8(5):4684-94. PubMed ID: 26191158
    [Abstract] [Full Text] [Related]

  • 15. Over-expression of interleukin-6 enhances cell survival and transformed cell growth in human malignant cholangiocytes.
    Meng F, Yamagiwa Y, Ueno Y, Patel T.
    J Hepatol; 2006 Jun 01; 44(6):1055-65. PubMed ID: 16469407
    [Abstract] [Full Text] [Related]

  • 16. MicroRNA-494-dependent WDHDI inhibition suppresses epithelial-mesenchymal transition, tumor growth and metastasis in cholangiocarcinoma.
    Liu B, Hu Y, Qin L, Peng XB, Huang YX.
    Dig Liver Dis; 2019 Mar 01; 51(3):397-411. PubMed ID: 30314946
    [Abstract] [Full Text] [Related]

  • 17. High-mobility group box 1 expression and lymph node metastasis in intrahepatic cholangiocarcinoma.
    Xu YF, Ge FJ, Han B, Yang XQ, Su H, Zhao AC, Zhao MH, Yang YB, Yang J.
    World J Gastroenterol; 2015 Mar 21; 21(11):3256-65. PubMed ID: 25805932
    [Abstract] [Full Text] [Related]

  • 18. Epigenetic alterations in cholangiocarcinoma-sustained IL-6/STAT3 signaling in cholangio- carcinoma due to SOCS3 epigenetic silencing.
    Isomoto H.
    Digestion; 2009 Mar 21; 79 Suppl 1():2-8. PubMed ID: 19153483
    [Abstract] [Full Text] [Related]

  • 19. Allicin Inhibits Proliferation and Invasion in Vitro and in Vivo via SHP-1-Mediated STAT3 Signaling in Cholangiocarcinoma.
    Chen H, Zhu B, Zhao L, Liu Y, Zhao F, Feng J, Jin Y, Sun J, Geng R, Wei Y.
    Cell Physiol Biochem; 2018 Mar 21; 47(2):641-653. PubMed ID: 29794468
    [Abstract] [Full Text] [Related]

  • 20. Akirin2 is modulated by miR-490-3p and facilitates angiogenesis in cholangiocarcinoma through the IL-6/STAT3/VEGFA signaling pathway.
    Leng K, Xu Y, Kang P, Qin W, Cai H, Wang H, Ji D, Jiang X, Li J, Li Z, Huang L, Zhong X, Sun X, Wang Z, Cui Y.
    Cell Death Dis; 2019 Mar 18; 10(4):262. PubMed ID: 30886152
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.